Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.
Identifieur interne : 000C44 ( PubMed/Checkpoint ); précédent : 000C43; suivant : 000C45Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.
Auteurs : E. Chokunonga [Zimbabwe] ; M Z Borok ; Z M Chirenje ; A M Nyakabau ; D M ParkinSource :
- International journal of cancer [ 1097-0215 ] ; 2013.
Descripteurs français
- KwdFr :
- Carcinome épidermoïde (épidémiologie), Femelle, Humains, Incidence, Lymphome malin non hodgkinien (épidémiologie), Mode de vie, Mâle, Risque, Sarcome de Kaposi (épidémiologie), Syndrome d'immunodéficience acquise (), Tumeurs (épidémiologie), Tumeurs de la prostate (épidémiologie), Tumeurs du col de l'utérus (épidémiologie), Tumeurs du sein (épidémiologie), Zimbabwe (épidémiologie).
- MESH :
- Wicri :
- geographic : Zimbabwe.
English descriptors
- KwdEn :
- Acquired Immunodeficiency Syndrome (complications), Breast Neoplasms (epidemiology), Carcinoma, Squamous Cell (epidemiology), Female, Humans, Incidence, Life Style, Lymphoma, Non-Hodgkin (epidemiology), Male, Neoplasms (epidemiology), Prostatic Neoplasms (epidemiology), Risk, Sarcoma, Kaposi (epidemiology), Uterine Cervical Neoplasms (epidemiology), Zimbabwe (epidemiology).
- MESH :
- geographic , epidemiology : Zimbabwe.
- complications : Acquired Immunodeficiency Syndrome.
- epidemiology : Breast Neoplasms, Carcinoma, Squamous Cell, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Sarcoma, Kaposi, Uterine Cervical Neoplasms.
- Female, Humans, Incidence, Life Style, Male, Risk.
Abstract
Incidence rates of different cancers have been calculated for the black population of Harare, Zimbabwe for a 20-year period (1991-2010) coinciding with continuing social and lifestyle changes, and the peak, and subsequent wane, of the HIV-AIDS epidemic. The overall risk of cancer increased during the period in both sexes, with rates of cervix and prostate cancers showing particularly dramatic increases (3.3% and 6.4% annually, respectively). By 2004, prostate cancer had become the most common cancer of men. The incidence of cancer of the esophagus, formerly the most common cancer of men, has remained relatively constant, whereas rates of breast and cervix cancers, the most common malignancies of women, have shown significant increases (4.9% and 3.3% annually, respectively). The incidence of Kaposi sarcoma increased to a maximum around 1998-2000 and then declined in all age groups, and in both sexes The incidence of squamous cell cancers of the conjunctiva is relatively high, with temporal trends similar to those of Kaposi sarcoma. Non-Hodgkin lymphoma, the fifth most common cancer of men and fourth of women, showed a steady increase in incidence throughout the period (6.7-6.9% annually), although rates in young adults (15-39) have decreased since 2001. Cancer control in Zimbabwe, as elsewhere in sub-Saharan Africa, involves meeting the challenge of emerging cancers associated with westernization of lifestyles (large bowel, breast and prostate), while the incidence of cancers associated with poverty and infection (liver, cervix and esophagus) shows little decline, and the residual burden of the AIDS-associated cancers remains significant.
DOI: 10.1002/ijc.28063
PubMed: 23364833
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:23364833Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.</title><author><name sortKey="Chokunonga, E" sort="Chokunonga, E" uniqKey="Chokunonga E" first="E" last="Chokunonga">E. Chokunonga</name><affiliation wicri:level="1"><nlm:affiliation>Zimbabwe National Cancer Registry, Harare, Zimbabwe.</nlm:affiliation><country xml:lang="fr">Zimbabwe</country><wicri:regionArea>Zimbabwe National Cancer Registry, Harare</wicri:regionArea><wicri:noRegion>Harare</wicri:noRegion></affiliation></author><author><name sortKey="Borok, M Z" sort="Borok, M Z" uniqKey="Borok M" first="M Z" last="Borok">M Z Borok</name></author><author><name sortKey="Chirenje, Z M" sort="Chirenje, Z M" uniqKey="Chirenje Z" first="Z M" last="Chirenje">Z M Chirenje</name></author><author><name sortKey="Nyakabau, A M" sort="Nyakabau, A M" uniqKey="Nyakabau A" first="A M" last="Nyakabau">A M Nyakabau</name></author><author><name sortKey="Parkin, D M" sort="Parkin, D M" uniqKey="Parkin D" first="D M" last="Parkin">D M Parkin</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="RBID">pubmed:23364833</idno><idno type="pmid">23364833</idno><idno type="doi">10.1002/ijc.28063</idno><idno type="wicri:Area/PubMed/Corpus">001324</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001324</idno><idno type="wicri:Area/PubMed/Curation">001324</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001324</idno><idno type="wicri:Area/PubMed/Checkpoint">001324</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001324</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.</title><author><name sortKey="Chokunonga, E" sort="Chokunonga, E" uniqKey="Chokunonga E" first="E" last="Chokunonga">E. Chokunonga</name><affiliation wicri:level="1"><nlm:affiliation>Zimbabwe National Cancer Registry, Harare, Zimbabwe.</nlm:affiliation><country xml:lang="fr">Zimbabwe</country><wicri:regionArea>Zimbabwe National Cancer Registry, Harare</wicri:regionArea><wicri:noRegion>Harare</wicri:noRegion></affiliation></author><author><name sortKey="Borok, M Z" sort="Borok, M Z" uniqKey="Borok M" first="M Z" last="Borok">M Z Borok</name></author><author><name sortKey="Chirenje, Z M" sort="Chirenje, Z M" uniqKey="Chirenje Z" first="Z M" last="Chirenje">Z M Chirenje</name></author><author><name sortKey="Nyakabau, A M" sort="Nyakabau, A M" uniqKey="Nyakabau A" first="A M" last="Nyakabau">A M Nyakabau</name></author><author><name sortKey="Parkin, D M" sort="Parkin, D M" uniqKey="Parkin D" first="D M" last="Parkin">D M Parkin</name></author></analytic><series><title level="j">International journal of cancer</title><idno type="eISSN">1097-0215</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acquired Immunodeficiency Syndrome (complications)</term><term>Breast Neoplasms (epidemiology)</term><term>Carcinoma, Squamous Cell (epidemiology)</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Life Style</term><term>Lymphoma, Non-Hodgkin (epidemiology)</term><term>Male</term><term>Neoplasms (epidemiology)</term><term>Prostatic Neoplasms (epidemiology)</term><term>Risk</term><term>Sarcoma, Kaposi (epidemiology)</term><term>Uterine Cervical Neoplasms (epidemiology)</term><term>Zimbabwe (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Carcinome épidermoïde (épidémiologie)</term><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Lymphome malin non hodgkinien (épidémiologie)</term><term>Mode de vie</term><term>Mâle</term><term>Risque</term><term>Sarcome de Kaposi (épidémiologie)</term><term>Syndrome d'immunodéficience acquise ()</term><term>Tumeurs (épidémiologie)</term><term>Tumeurs de la prostate (épidémiologie)</term><term>Tumeurs du col de l'utérus (épidémiologie)</term><term>Tumeurs du sein (épidémiologie)</term><term>Zimbabwe (épidémiologie)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Zimbabwe</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Acquired Immunodeficiency Syndrome</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma, Squamous Cell</term><term>Lymphoma, Non-Hodgkin</term><term>Neoplasms</term><term>Prostatic Neoplasms</term><term>Sarcoma, Kaposi</term><term>Uterine Cervical Neoplasms</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Carcinome épidermoïde</term><term>Lymphome malin non hodgkinien</term><term>Sarcome de Kaposi</term><term>Tumeurs</term><term>Tumeurs de la prostate</term><term>Tumeurs du col de l'utérus</term><term>Tumeurs du sein</term><term>Zimbabwe</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Female</term><term>Humans</term><term>Incidence</term><term>Life Style</term><term>Male</term><term>Risk</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Femelle</term><term>Humains</term><term>Incidence</term><term>Mode de vie</term><term>Mâle</term><term>Risque</term><term>Syndrome d'immunodéficience acquise</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Zimbabwe</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Incidence rates of different cancers have been calculated for the black population of Harare, Zimbabwe for a 20-year period (1991-2010) coinciding with continuing social and lifestyle changes, and the peak, and subsequent wane, of the HIV-AIDS epidemic. The overall risk of cancer increased during the period in both sexes, with rates of cervix and prostate cancers showing particularly dramatic increases (3.3% and 6.4% annually, respectively). By 2004, prostate cancer had become the most common cancer of men. The incidence of cancer of the esophagus, formerly the most common cancer of men, has remained relatively constant, whereas rates of breast and cervix cancers, the most common malignancies of women, have shown significant increases (4.9% and 3.3% annually, respectively). The incidence of Kaposi sarcoma increased to a maximum around 1998-2000 and then declined in all age groups, and in both sexes The incidence of squamous cell cancers of the conjunctiva is relatively high, with temporal trends similar to those of Kaposi sarcoma. Non-Hodgkin lymphoma, the fifth most common cancer of men and fourth of women, showed a steady increase in incidence throughout the period (6.7-6.9% annually), although rates in young adults (15-39) have decreased since 2001. Cancer control in Zimbabwe, as elsewhere in sub-Saharan Africa, involves meeting the challenge of emerging cancers associated with westernization of lifestyles (large bowel, breast and prostate), while the incidence of cancers associated with poverty and infection (liver, cervix and esophagus) shows little decline, and the residual burden of the AIDS-associated cancers remains significant.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">23364833</PMID><DateCreated><Year>2013</Year><Month>05</Month><Day>22</Day></DateCreated><DateCompleted><Year>2013</Year><Month>07</Month><Day>25</Day></DateCompleted><DateRevised><Year>2016</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-0215</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>International journal of cancer</Title><ISOAbbreviation>Int. J. Cancer</ISOAbbreviation></Journal><ArticleTitle>Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.</ArticleTitle><Pagination><MedlinePgn>721-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ijc.28063</ELocationID><Abstract><AbstractText>Incidence rates of different cancers have been calculated for the black population of Harare, Zimbabwe for a 20-year period (1991-2010) coinciding with continuing social and lifestyle changes, and the peak, and subsequent wane, of the HIV-AIDS epidemic. The overall risk of cancer increased during the period in both sexes, with rates of cervix and prostate cancers showing particularly dramatic increases (3.3% and 6.4% annually, respectively). By 2004, prostate cancer had become the most common cancer of men. The incidence of cancer of the esophagus, formerly the most common cancer of men, has remained relatively constant, whereas rates of breast and cervix cancers, the most common malignancies of women, have shown significant increases (4.9% and 3.3% annually, respectively). The incidence of Kaposi sarcoma increased to a maximum around 1998-2000 and then declined in all age groups, and in both sexes The incidence of squamous cell cancers of the conjunctiva is relatively high, with temporal trends similar to those of Kaposi sarcoma. Non-Hodgkin lymphoma, the fifth most common cancer of men and fourth of women, showed a steady increase in incidence throughout the period (6.7-6.9% annually), although rates in young adults (15-39) have decreased since 2001. Cancer control in Zimbabwe, as elsewhere in sub-Saharan Africa, involves meeting the challenge of emerging cancers associated with westernization of lifestyles (large bowel, breast and prostate), while the incidence of cancers associated with poverty and infection (liver, cervix and esophagus) shows little decline, and the residual burden of the AIDS-associated cancers remains significant.</AbstractText><CopyrightInformation>Copyright © 2013 UICC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chokunonga</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Zimbabwe National Cancer Registry, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borok</LastName><ForeName>M Z</ForeName><Initials>MZ</Initials></Author><Author ValidYN="Y"><LastName>Chirenje</LastName><ForeName>Z M</ForeName><Initials>ZM</Initials></Author><Author ValidYN="Y"><LastName>Nyakabau</LastName><ForeName>A M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Parkin</LastName><ForeName>D M</ForeName><Initials>DM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>03</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Int J Cancer</MedlineTA><NlmUniqueID>0042124</NlmUniqueID><ISSNLinking>0020-7136</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002294" MajorTopicYN="N">Carcinoma, Squamous Cell</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008019" MajorTopicYN="N">Life Style</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008228" MajorTopicYN="N">Lymphoma, Non-Hodgkin</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011471" MajorTopicYN="N">Prostatic Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012514" MajorTopicYN="N">Sarcoma, Kaposi</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002583" MajorTopicYN="N">Uterine Cervical Neoplasms</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015030" MajorTopicYN="N" Type="Geographic">Zimbabwe</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>01</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23364833</ArticleId><ArticleId IdType="doi">10.1002/ijc.28063</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Zimbabwe</li></country></list><tree><noCountry><name sortKey="Borok, M Z" sort="Borok, M Z" uniqKey="Borok M" first="M Z" last="Borok">M Z Borok</name><name sortKey="Chirenje, Z M" sort="Chirenje, Z M" uniqKey="Chirenje Z" first="Z M" last="Chirenje">Z M Chirenje</name><name sortKey="Nyakabau, A M" sort="Nyakabau, A M" uniqKey="Nyakabau A" first="A M" last="Nyakabau">A M Nyakabau</name><name sortKey="Parkin, D M" sort="Parkin, D M" uniqKey="Parkin D" first="D M" last="Parkin">D M Parkin</name></noCountry><country name="Zimbabwe"><noRegion><name sortKey="Chokunonga, E" sort="Chokunonga, E" uniqKey="Chokunonga E" first="E" last="Chokunonga">E. Chokunonga</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C44 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000C44 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaSubSaharaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:23364833
|texte= Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991-2010.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:23364833" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a SidaSubSaharaV1
| This area was generated with Dilib version V0.6.32. |  |